AMR

Petri dish used for bacterial research
#AMR #Antibiotic resistance #Antibiotics #Harvard Medical School #Roche

Excitement over new antibiotics that can kill drug-resistant bacteria

A novel antibiotic class targeting a major global pathogen and threat to human health has been discovered by scientists from Roche and Harvard University (Cambridge, MA, US). In two studies published in Nature, the authors demonstrate that the new class of drug candidates can effectively target… Read More

#News #Trending News

Antibiotics
#AMR #Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Immunology / Virology & Vaccines #University of Queensland

Global crisis of antibiotic resistance is “inevitable”

A report by University of Queensland (UQ) researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics. The Centre for Superbug Solutions at UQ’s Institute for Molecular Bioscience has monitored the clinical pipeline for more than a decade, with… Read More

#Editor's Choice #News

#AMR #Covid-19 #Diabetes #Drug development #FDA #Genetics / genomics #Influenza #Parasitic disease

New DDW Highlights podcast: 10 July 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  It’s been a fascinating week in drug discovery, as AstraZeneca announced that its Phase III trial… Read More

#News

#AMR #Covid-19 #Diabetes #Drug development #FDA #Genetics / genomics #Influenza #Parasitic disease

This week in drug discovery (3-7 July)  

News round-up for 3-7 July by DDW Digital Content Editor Diana Spencer. It’s been a fascinating week in drug discovery, as AstraZeneca announced that its Phase III trial of datopotamab deruxtecan did not meet its second primary endpoint and saw an 8% drop in its stock… Read More

#News

#AMR #CDMO #Covid-19 #Immunology / Virology & Vaccines #RNA

Vaccine nationalism, AMR & CDMO expansion ahead for 2021

The new CPhI report looks ahead to a post-pandemic 2021 with pharma manufacturing capacity and payment structures shifting as new sourcing strategies emerge. It explores the potential implications in 2021 of impending vaccine approvals, a new administration in the White House and a return to dual supply chain strategies. The report… Read More

#Business & Investment #Covid-19 #Editor's Choice #Market Reports #News

#AMR #Antibiotics #Laboratory of the Future

Analytica virtual conference: new approaches in the fight against antibiotic resistance

The Analytica conference accompanies Analytica 2020, which is currently taking place virtually until 23 October. Key topics in focus at the event are  antibiotic resistance and the ‘laboratory of the future’. The number of microbes that are resistant to certain classes of antibiotics is increasing – hampering therapy. Humans and… Read More

#News